Evidence map›Paper›PMID 30945968›Full record

ArticleHuman vaccines & immunotherapeutics2019

Implementing pharmacy-located HPV vaccination: findings from pilot projects in five U.S. states.

William A Calo, Parth D Shah, Melissa B Gilkey, Robin C Vanderpool, Sarah Barden, William R Doucette, Noel T Brewer

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pharmacy-based immunization: a systematic review.Frontiers in public health · 2023
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

William A Caloa Department of Public Health Sciences, Penn State College of Medicine , Hershey , PA , USA.ORCID 0000-0001-8452-5063
Parth D Shahc The Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center , Seattle , WA , USA.ORCID 0000-0002-3536-6219
Melissa B Gilkeyd Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina , Chapel Hill , NC , USA.
Robin C Vanderpoolf Department of Health, Behavior and Society, College of Public Health, University of Kentucky , Lexington , KY , USA.
Sarah Bardeng Michigan Pharmacists Association , Lansing , MI , USA.
William R Doucetteh Health Services Research Division, University of Iowa College of Pharmacy , Iowa City , IA , USA.
Noel T Brewerd Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina , Chapel Hill , NC , USA.ORCID 0000-0003-2241-7002
University of North Carolina at Chapel Hill · USFred Hutch Cancer Center · USMichigan Pharmacists Association · USPennsylvania State University · USUniversity of Iowa · USUniversity of Kentucky · US

Funding

Cancer Control Education ProgramT32CA057726 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa B Gilkey, Melissa A. Troester · 2017 to 2026
$3.7M
Improving Healthcare Providers' Communication about HPV VaccineK22CA186979 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GILKEY, MELISSA B · 2014 to 2016
$553k
AHRQ HHS T32 HS000032NCI NIH HHS K22 CA186979NCI NIH HHS T32 CA057726
6 · The paper itself

Abstract

Pharmacies are promising alternative settings for human papillomavirus (HPV) vaccination because of their population reach, convenience, and existing infrastructure for vaccine delivery. However, pharmacies in the US are rarely used for adolescent HPV vaccination. We sought to document challenges and opportunities of implementing pharmacy-located HPV vaccination services in five US states by mapping process evaluation results onto key implementation science constructs: service penetration, acceptability, appropriateness, feasibility, fidelity, adoption, and sustainability. Pilot projects were planned in North Carolina (k = 2 pharmacies), Michigan (k = 10), Iowa (k = 2), Kentucky (k = 1), and Oregon (no pharmacy recruited) with varying procedures and recruitment strategies. Sites had open enrollment for a combined 12 months. Despite substantial efforts in these states, only 13 HPV vaccine doses were administered to adolescents and three doses to age-eligible young adults. We identified two major reasons for these underperforming results. First, poor outcomes on service penetration and appropriateness pointed to engagement barriers: low parent demand and engagement among pharmacy staff. Second, poor outcomes on feasibility, adoption, and sustainability appeared to result from administrative hurdles: lacking third party reimbursement (i.e., billing commercial payers, participation in Vaccines for Children program) and limited integration into primary care systems. In summary, pilot projects in five states all struggled to administer HPV vaccines. Opportunities for making pharmacies a successful setting for adolescent HPV vaccination include expanding third party reimbursement to cover all vaccines administered by pharmacists, increasing public awareness of pharmacists' immunization training, and improving care coordination with primary care providers.

Indexed as

Health Plan ImplementationAdolescentAdultFemaleHumansMalePapillomavirus InfectionsPapillomavirus VaccinesParentsPatient Acceptance of Health CarePharmaciesPilot ProjectsSurveys and QuestionnairesUnited StatesVaccinationYoung AdultPapillomavirus Vaccinesalternative vaccination settingsHPV vaccineimplementation sciencepharmaciespharmacistsscope of practice

Identifiers

PMID30945968
PMCPMC6746514
OpenAlexW2933662394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.